Correction to: Rebuttal letter on “Comment on tumor necrosis factor inhibitors prevent structural damage in hips in ankylosing spondylitis—time to reconsider treatment guidelines? A case series and review of literature” (Clinical Rheumatology, (2021), 40, 5, (2107-2108), 10.1007/s10067-021-05705-8)

Francisco Airton Castro Rocha, Atul Deodhar

Research output: Contribution to journal › Comment/debate › peer-review

Fingerprint

Dive into the research topics of 'Correction to: Rebuttal letter on “Comment on tumor necrosis factor inhibitors prevent structural damage in hips in ankylosing spondylitis—time to reconsider treatment guidelines? A case series and review of literature” (Clinical Rheumatology, (2021), 40, 5, (2107-2108), 10.1007/s10067-021-05705-8)'. Together they form a unique fingerprint.

Medicine & Life Sciences